{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:21:18Z","timestamp":1793863278822,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Manatu Hauora | Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["13_065"],"award-info":[{"award-number":["13_065"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Manatu Hauora | Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["13_065"],"award-info":[{"award-number":["13_065"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","award":["JT383"],"award-info":[{"award-number":["JT383"]}],"id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","award":["JT383"],"award-info":[{"award-number":["JT383"]}],"id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41435-020-0102-z","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T13:03:00Z","timestamp":1591707780000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The contribution from interleukin-27 towards rheumatoid inflammation: insights from gene expression"],"prefix":"10.1038","volume":"21","author":[{"given":"Melanie J.","family":"Millier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-1242","authenticated-orcid":false,"given":"Paul A.","family":"Hessian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"102_CR1","doi-asserted-by":"publisher","first-page":"988.","DOI":"10.3389\/fimmu.2019.00988","volume":"10","author":"D Bastian","year":"2019","unstructured":"Bastian D, Wu Y, Betts BC, Yu XZ. The IL-12 cytokine and receptor family in graft-vs-host disease. Front Immunol. 2019;10:988. https:\/\/doi.org\/10.3389\/fimmu.2019.00988.","journal-title":"Front Immunol."},{"key":"102_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ni.1957","volume":"11","author":"JS Stumhofer","year":"2010","unstructured":"Stumhofer JS, Tait ED, Quinn WJ, Hosken N, Spudy B, Goenka R, et al. A role for Il-27p28 as an antagonist of gp130-mediated signalling. Nat Immunol. 2010;11:1119\u201326.","journal-title":"Nat Immunol."},{"key":"102_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Hibbert L, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of na\u00efve CD4+ T cells. Immunity. 2002;16:779\u201390.","journal-title":"Immunity."},{"key":"102_CR4","doi-asserted-by":"publisher","first-page":"256.","DOI":"10.3389\/fimmu.2018.00256","volume":"9","author":"C Petes","year":"2018","unstructured":"Petes C, Mariani MK, Yang Y, Grandvaux N, Gee K. Interleukin (IL)-6 inhibits IL-27- and IL-30-mediated inflammatory responses in human monocytes. Front Immunol. 2018;9:256. https:\/\/doi.org\/10.3389\/fimmu.2018.00256.","journal-title":"Front Immunol"},{"key":"102_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1073\/pnas.1816698116","volume":"116","author":"SI Muller","year":"2019","unstructured":"Muller SI, Friedl A, Aschenbrenner I, Esser-von Bieren J, Zacharias M, Devergne O, et al. A folding switch regulates interleukin biogenesis and secretion of it \u03b1-subunit as a cytokine. Proc Nat Acad Sci USA. 2019;116:1585\u201390.","journal-title":"Proc Nat Acad Sci USA."},{"key":"102_CR6","doi-asserted-by":"publisher","unstructured":"Laroni A, Gandhi R, Beynon V, Weiner HL. IL-27 imparts immunoregulatory function to human NK cells subsets. PLoS ONE. 6:e26173. https:\/\/doi.org\/10.1371\/journal.pone.0026173.","DOI":"10.1371\/journal.pone.0026173"},{"key":"102_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00005-010-0098-6","volume":"58","author":"M Jankowski","year":"2010","unstructured":"Jankowski M, Kopinski P, Goc A. Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp. 2010;58:417\u201325.","journal-title":"Arch Immunol Ther Exp"},{"key":"102_CR8","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/ar3067","volume":"12","author":"CK Wong","year":"2010","unstructured":"Wong CK, Chen DP, Tam LS, Li EK, Yin YB, Lam CW. Effects of inflammatory cytokineIL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arth Res Ther. 2010;12:R129.","journal-title":"Arth Res Ther"},{"key":"102_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4049\/jimmunol.173.2.1171","volume":"173","author":"R Goldberg","year":"2004","unstructured":"Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralising the function of the p28 subunit of IL-27. J Immunol. 2004;173:1171\u20138.","journal-title":"J Immunol."},{"key":"102_CR10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20132307","volume":"212","author":"GW Jones","year":"2015","unstructured":"Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med. 2015;212:1793\u2013802.","journal-title":"J Exp Med"},{"key":"102_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/art.30180","volume":"63","author":"H Shen","year":"2011","unstructured":"Shen H, Xia L, Xiao W, Lu J. Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arth Rheum. 2011;63:860\u20131.","journal-title":"Arth Rheum"},{"key":"102_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2011.04.020","volume":"55","author":"S Tanida","year":"2011","unstructured":"Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata, Shibuya H, et al. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. Cytokine. 2011;55:237\u201344.","journal-title":"Cytokine."},{"key":"102_CR13","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.jaut.2019.06.009","volume":"105","author":"KF Baker","year":"2019","unstructured":"Baker KF, Skelton AJ, Lendrem DW, Scadeng A, Thompson B, Pratt AG, et al. Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study. J Autoimmun. 2019;105:102298.","journal-title":"J Autoimmun."},{"key":"102_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/art.10776","volume":"48","author":"PA Hessian","year":"2003","unstructured":"Hessian PA, Highton J, Kean A, Sun CK, Chin M. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arth Rheum. 2003;48:334\u20138.","journal-title":"Arth Rheum"},{"key":"102_CR15","doi-asserted-by":"publisher","first-page":"737310.","DOI":"10.1155\/2015\/737310","volume":"2015","author":"SA Dorosz","year":"2015","unstructured":"Dorosz SA, Ginolhac A, Kahne T, Naumann M, Salamann Sauter T. et al. Role of calprotectin as a modulator of the IL27-mediated proinflammatory effect on endothelial cells. Mediators Inflamm. 2015;2015:737310.","journal-title":"Mediators Inflamm"},{"key":"102_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202135","volume":"16","author":"KJ McKelvey","year":"2018","unstructured":"McKelvey KJ, Millier MJ, Doyle TC, Stamp LK, Highton J, Hessian PA. Co-expression of CD21l and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation. PLoS ONE. 2018;16:e0202135.","journal-title":"PLoS ONE."},{"key":"102_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0060001","volume":"6","author":"F Humby","year":"2009","unstructured":"Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6:e1.","journal-title":"PLoS Med."},{"key":"102_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00541376","volume":"7","author":"DG Palmer","year":"1987","unstructured":"Palmer DG, Hogg N, Denholm I, Allen CA, Highton J, Hessian PA. Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules. Rheumatol Int. 1987;7:187\u201393.","journal-title":"Rheumatol Int."},{"key":"102_CR19","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1096\/fj.201802386R","volume":"33","author":"S Soni","year":"2019","unstructured":"Soni S, O\u2019Dea KP, Tan YY, Cho K, Abe E, Romano R, et al. ATP directs cytokine trafficking and promotes novel membrane TNF signalling via micro-vesicles. FASEB J. 2019;33:6442\u201355.","journal-title":"FASEB J."},{"key":"102_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/rheumatology\/kem163","volume":"46","author":"J Highton","year":"2007","unstructured":"Highton J, Hessian PA, Stamp L. The rheumatoid nodule: peripheral or central to rheumatoid arthritis. Rheumatology. 2007;46:1385\u20137.","journal-title":"Rheumatology"},{"key":"102_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/rheumatology\/kel411","volume":"46","author":"J Highton","year":"2007","unstructured":"Highton J, Hung N, Hessian P, Wilsher M. Pulmonary rheumatoid nodules demonstrating features usually associated with synovial membrane. Rheumatology. 2007;46:811\u20134.","journal-title":"Rheumatology"},{"key":"102_CR22","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.23455","volume":"58","author":"LK Stamp","year":"2008","unstructured":"Stamp LK, Eason A, Lehnigk U, Highton J, Hessian PA. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arth Rheum. 2008;58:1601\u20138.","journal-title":"Arth Rheum"},{"key":"102_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/jir.2010.0115","volume":"31","author":"H Liu","year":"2011","unstructured":"Liu H, Rohowsky-Kochan C. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signalling protein 1. J Interferon Cytokine Res. 2011;31:459\u201369.","journal-title":"J Interferon Cytokine Res."},{"key":"102_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.1508","volume":"202","author":"F Larousserie","year":"2004","unstructured":"Larousserie F, Pflanz S, Coulomb-L\u2019Hermine A, Brousse N, Kastelein R, Cevergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Path. 2004;202:164\u201371.","journal-title":"J Path"},{"key":"102_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4049\/jimmunol.180.2.922","volume":"180","author":"Y Cao","year":"2008","unstructured":"Cao Y, Doodes PD, Glant TT, Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol. 2008;180:922\u201330.","journal-title":"J Immunol."},{"key":"102_CR26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s10067-013-2341-0","volume":"32","author":"F Gong","year":"2013","unstructured":"Gong F, Pan Y-H, Huang X, Chen J, Xiao J, Zhu H. Interleukin-27 as a potential therapeutic target for rheumatoid arthritis: has the time come? Clin Rheumatol. 2013;32:1425\u20138.","journal-title":"Clin Rheumatol."},{"key":"102_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cei.13116","volume":"193","author":"GW Jones","year":"2018","unstructured":"Jones GW, Hill DG, Cardua A, Jones SA. Il-27: a double agent in the IL-6 family. Clin Exp Immunol. 2018;193:37\u201346.","journal-title":"Clin Exp Immunol."},{"key":"102_CR28","doi-asserted-by":"publisher","first-page":"173.","DOI":"10.1186\/s13075-015-0688-0","volume":"17","author":"JD Canete","year":"2015","unstructured":"Canete JD, Celis R, Yeremenko N, Sanmarti R, van Duivenvoorde L, Ramirez J, et al. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arth Res Ther. 2015;17:173. https:\/\/doi.org\/10.1186\/s13075-015-0688-0.","journal-title":"Arth Res Ther"},{"key":"102_CR29","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1084\/jem.20100064","volume":"201","author":"M Batten","year":"2010","unstructured":"Batten M, Ramamoorrthi N, Kijavin NM, Ma CS, Cox J, Dengler HS, et al. IL-27 supports germinal centre function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med. 2010;201:2895\u2013906.","journal-title":"J Exp Med"},{"key":"102_CR30","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.4049\/jimmunol.1600652","volume":"197","author":"D Vijayan","year":"2016","unstructured":"Vijayan D, Mohd Redzwan N, Avery DT, Wirasinha RC, Brink R, Walters G, et al. IL-27 directly enhances germinal centre B cell activity and potentiates Lupus in sanroque mice. J Immunol. 2016;197:3008\u201317.","journal-title":"J Immunol."},{"key":"102_CR31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"RX Wang","year":"2014","unstructured":"Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20:633\u201341.","journal-title":"Nat Med."},{"key":"102_CR32","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.4049\/jimmunol.174.12.7684","volume":"15","author":"AV Villarino","year":"2005","unstructured":"Villarino AV, Larkin J, Saris CJ, Caton AJ, Lucas S, Wong T, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;15:7684\u201391.","journal-title":"J Immunol."},{"key":"102_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","volume":"101","author":"AK Mehta","year":"2018","unstructured":"Mehta AK, Gracias DT, Croft M. TNF activity and T cells. Cytokine. 2018;101:14\u201318.","journal-title":"Cytokine."},{"key":"102_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17619-0","volume":"7","author":"MJ Millier","year":"2018","unstructured":"Millier MJ, Stamp LK, Hessian PA. Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Sci Rep. 2018;7:17235. https:\/\/doi.org\/10.1038\/s41598-017-17619-0.","journal-title":"Sci Rep"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0102-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-020-0102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:33Z","timestamp":1684617333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-020-0102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1038\/s41435-020-0102-z","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"22 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}